Menaxi Pharmaceuticals Llp

Manufactures and distributes herbal and homeopathic beauty, hair, and skin products.

2016 | Mumbai, Maharashtra (India) | Active
Last Updated: January 22, 2024

Menaxi Pharmaceuticals Llp Profile

Key Indicators

  • Obligation of Contribution ₹ 0.31 M
  • Company Age 8 Year, 10 Months
  • Last Filing with ROC 31 Mar 2023

About Menaxi Pharmaceuticals Llp

Menaxi Pharmaceuticals Llp (MPL) is 8 Year, 10 Months old Limited Liability Partnership 31 March 2016. Its registered office is in Mumbai, Maharashtra, India.

The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2023 (FY 2022-2023). It's Total Obligation of Contribution is Rs 0.31 M as per MCA.

Company Details

  • Location

    Mumbai, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address
  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN/FCRN

    AAG-1049

  • Incorporation Date

    31 Mar 2016

  • Date of Accounts and Solvency Statement

    31 Mar 2023

  • ROC Code

    Roc-Mumbai

  • Company Classification

    Limited Liability Partnership

Industry

FMCG

Who are the key members and board of directors at Menaxi Pharmaceuticals Llp?

Designated Partners (3)

Name Designation Appointment Date Status
Apoorva Shah Country flag representing In Designated Partner 31-Mar-2016 Current
Suyomi Shah Country flag representing In Designated Partner 31-Mar-2016 Current
Shaurya Shah Country flag representing In Designated Partner 31-Mar-2016 Current

Financial Performance of Menaxi Pharmaceuticals Llp.

Enhance accessibility to Menaxi Pharmaceuticals Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
Revenue from Operations
Total Assets
Profit or Loss
Net Worth
EBITDA

What is the Ownership and Shareholding Structure of Menaxi Pharmaceuticals Llp?

Unlock access to Menaxi Pharmaceuticals Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no Open Charges registered against the LLP as per our records.

How Many Employees Work at Menaxi Pharmaceuticals Llp?

Unlock and access historical data on people associated with Menaxi Pharmaceuticals Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Menaxi Pharmaceuticals Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Menaxi Pharmaceuticals Llp's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Menaxi Pharmaceuticals Llp

Recent activity within the organization

  • Statement of Assets & Liabilities

    Menaxi Pharmaceuticals Llp has filed its annual Financial statements for the year ended 31 Mar 2023 with RoC-Mumbai.

    31 Mar 2023

  • Director Appointment

    Apoorva Rajnikant Shah was appointed as a Designated Partner was appointed as a Designated Partner on 31 Mar 2016 & has been associated with this company since 8 years 10 months .

    31 Mar 2016

  • Director Appointment

    Suyomi Apoorva Shah was appointed as a Designated Partner was appointed as a Designated Partner on 31 Mar 2016 & has been associated with this company since 8 years 10 months .

    31 Mar 2016

  • Director Appointment

    Shaurya Apoorva Shah was appointed as a Designated Partner was appointed as a Designated Partner on 31 Mar 2016 & has been associated with this company since 8 years 10 months .

    31 Mar 2016

  • LLP Incorporation

    Menaxi Pharmaceuticals Llp was registered on 31 Mar 2016 with RoC-Mumbai & aged 8 years 10 months as per MCA records.

    31 Mar 2016

Frequently asked questions

  • Menaxi Pharmaceuticals Llp was incorporated on 31 Mar 2016.

  • The Obligation of Contribution of Menaxi Pharmaceuticals Llp is ₹ 0.31 M.

  • Currently 3 partners are associated with Menaxi Pharmaceuticals Llp.

    • Apoorva Rajnikant Shah
    • Suyomi Apoorva Shah
    • Shaurya Apoorva Shah
    Apoorva Rajnikant ShahSuyomi Apoorva ShahShaurya Apoorva Shah
  • As per Ministry of Corporate Affairs (Mca), the registered address of Menaxi Pharmaceuticals Llp is 198/13 Shri Jagdish Niwas Co-Op Hsg. Sty. Opp. Gtb Railway Station, Sion (East) Na City, Mumbai, Maharashtra, India, 400022.

  • The Limited Liability Partnership Identification Number (LLPIN) of Menaxi Pharmaceuticals Llp is AAG-1049.

  • The most recent Balance Sheet for Menaxi Pharmaceuticals Llp was filed with the ROC on 31 Mar 2023.